Association of serum and crevicular visfatin levels in periodontal health and disease with type 2 diabetes mellitus

Journal of Periodontology

Volumn 83, Issue 5, 2012, Pages 629-634

  Pradeep, A R ^a   Raghavendra, N M ^a   Sharma, Anuj ^a   Patel, Swati Pradeep ^a   Raju, Arjun ^b   Kathariya, Rahul ^a   Rao, Nishanth S ^a   Naik, Savitha B ^a  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

^b Bangalore Medical College and Research Institute ^*  (India)

Author keywords

Adipokines; Cardiovascular diseases; Diabetes mellitus; Nicotinamide phosphoribosyltransferase, human

Indexed keywords

NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHRONIC PERIODONTITIS; ENZYMOLOGY; FEMALE; GINGIVITIS; HUMAN; LONGITUDINAL STUDY; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPARAMETRIC TEST;

ADULT; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; DIABETES MELLITUS, TYPE 2; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84860495682     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2011.110272     Document Type: Article

References (22)

1. Graves DT, Cochran D. The contribution of interleu-kin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003;74:391-401. (Pubitemid 36939356)
2. Mengel R, Bacher M, Flores-De-Jacoby L. Interactions between stress, interleukin-1beta, interleukin-6 and cortisol in periodontally diseased patients. J Clin Periodontol 2002;29:1012-1022. (Pubitemid 41697771)
3. Saito T, Shimazaki Y, Sakamoto M. Obesity and peri-odontitis. N Engl J Med 1998;339:482-483.
4. Saito T, Shimazaki Y, Kiyohara Y, et al. The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: The Hisayama study. J Dent Res 2004;83:485-490. (Pubitemid 41756845)
5. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol 2005; 76(Suppl. 11)2075-2084. (Pubitemid 41748956)
6. Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y. Relationship of metabolic syndrome to periodontal disease in Japanese women: The Hi-sayama Study. J Dent Res 2007;86:271-275.
7. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
8. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911-919, quiz 920.
9. Moschen AR, Kaser A, Enrich B, et al. Visfatin, an adipocytokine with proinflammatory and immunomo-dulating properties. J Immunol 2007;178:1748-1758. (Pubitemid 46154646)
10. Pradeep AR, Raghavendra N, Prasad MV, Kathariya R, Pradeep Patel S, Sharma A. Gingival crevicular fluid and serum visfatin concentration: Their relationship in periodontal health and disease. J Periodontol. 2011; 82:1314-1319.
11. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363: 157-163 (erratum 2004;363:902).
12. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 21:533-551.
13. Executive summary: Standards of medical care in diabetes\2010. Diabetes Care 2010;33(Suppl. 1): S4-S10.
14. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-430. (Pubitemid 40139988)
15. McGlothlin JR, Gao L, Lavoie T, et al. Molecular cloning and chrecterization of canine pre B-cell colony enhancing factor. Biochem Genet 2005;43: 127-141. (Pubitemid 40543710)
16. Dahl TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: Possible role in inflammation and plaque destabilization. Circulation 2007;115:972-980. (Pubitemid 46328290)
17. Sandeep S, Velmurugan K, Deepa R, Mohan V. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. Metabolism 2007;56: 565-570. (Pubitemid 46427855)
18. Brentano F, Schorr O, Ospelt C, et al. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum 2007;56: 2829-2839. (Pubitemid 47502729)
19. Ye SQ, Simon BA, Maloney JP, et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 2005;171:361-370. (Pubitemid 40223404)
20. Xie H, Tang SY, Luo XH, et al. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007; 80:201-210. (Pubitemid 46411878)
21. Bae YH, Bae MK, Kim SR, Lee JH, Wee HJ, Bae SK. Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis. Biochem Bio-phys Res Commun 2009;379:206-211.
22. Gosset M, Berenbaum F, Salvat C, et al. Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: Possible influence on osteoarthri-tis. Arthritis Rheum 2008;58:1399-1409. (Pubitemid 351705929)